Literature DB >> 16733862

Prevalence of occult HBV infection in haemodialysis patients with chronic HCV.

Vedat Goral1, Hamza Ozkul, Selahattin Tekes, Dede Sit, Ali Kemal Kadiroglu.   

Abstract

AIM: To study the prevalence and clinical effects of occult HBV infection in haemodialysis patients with chronic HCV.
METHODS: Fifty chronic hemodialysis patients with negative HbsAg, and positive anti-HCV were included in the study. These patients were divided into two groups: HCV-RNA positive and HCV-RNA negative, based on the results of HCV-RNA PCR. HBV-DNA was studied using the PCR method in both groups.
RESULTS: None of the 22 HCV-RNA positive patients and 28 HCV-RNA negative patients revealed HBV-DNA in serum by PCR method. The average age was 47.2 +/- 17.0 in the HCV-RNA positive group and 39.6 +/- 15.6 in the HCV-RNA negative group.
CONCLUSION: The prevalence of occult HBV infection is not high in haemodialysis patients with chronic HCV in our region. This result of our study has to be evaluated in consideration of the interaction between HBsAg positivity (8%-10%) and frequency of HBV mutants in our region.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16733862      PMCID: PMC4087876          DOI: 10.3748/wjg.v12.i21.3420

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C.

Authors:  L Kazemi-Shirazi; D Petermann; C Müller
Journal:  J Hepatol       Date:  2000-11       Impact factor: 25.083

2.  Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period.

Authors:  K Iwai; M Tashima; M Itoh; T Okazaki; K Yamamoto; H Ohno; H Marusawa; Y Ueda; T Nakamura; T Chiba; T Uchiyama
Journal:  Bone Marrow Transplant       Date:  2000-01       Impact factor: 5.483

Review 3.  Occult hepatitis B virus infection in patients with hepatocellular carcinoma: Innocent bystander, cofactor, or culprit?

Authors:  Jorge A Marrero; Anna S F Lok
Journal:  Gastroenterology       Date:  2004-01       Impact factor: 22.682

4.  Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection.

Authors:  Fatih Besisik; Cetin Karaca; Filiz Akyüz; Sibel Horosanli; Derya Onel; Selim Badur; Mehmet Sükrü Sever; Ahmet Danalioglu; Kadir Demir; Sabahattin Kaymakoglu; Yilmaz Cakaloglu; Atilla Okten
Journal:  J Hepatol       Date:  2003-04       Impact factor: 25.083

5.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology.

Authors:  C Berasain; M Betés; A Panizo; J Ruiz; J I Herrero; M P Civeira; J Prieto
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

6.  Hepatitis B infection in patients with acute liver failure in the United States.

Authors:  E K Teo; G Ostapowicz; M Hussain; W M Lee; R J Fontana; A S Lok
Journal:  Hepatology       Date:  2001-04       Impact factor: 17.425

7.  Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus-positive patients.

Authors:  Edoardo Giannini; Paola Ceppa; Federica Botta; Alberto Fasoli; Paola Romagnoli; Filippo Ansaldi; Paolo Durando; Domenico Risso; Pasquale B Lantieri; Gian C Icardi; Roberto Testa
Journal:  Liver Int       Date:  2003-02       Impact factor: 5.828

8.  Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C.

Authors:  D Ferraro; C Bonura; M Giglio; R Di Stefano; P L Almasio; V Di Marco; A Craxì; I Cacciola; G Squadrito; G Raimondo
Journal:  J Biol Regul Homeost Agents       Date:  2003 Apr-Jun       Impact factor: 1.711

Review 9.  Occult hepatitis B virus infection and its clinical implications.

Authors:  Ke-Qin Hu
Journal:  J Viral Hepat       Date:  2002-07       Impact factor: 3.728

Review 10.  Occult hepatitis B virus infection: implications in transfusion.

Authors:  J-P Allain
Journal:  Vox Sang       Date:  2004-02       Impact factor: 2.144

View more
  17 in total

1.  HBV reactivation in a patient on chronic haemodialysis treatment.

Authors:  Gioacchino Li Cavoli; Natalia Li Destri; Tancredi Vincenzo Li Cavoli; Mattia Palmeri; Franca Servillo; Ugo Rotolo
Journal:  CEN Case Rep       Date:  2015-01-13

Review 2.  Occult hepatitis B virus infection in Egypt.

Authors:  Ashraf Elbahrawy; Alshimaa Alaboudy; Walid El Moghazy; Ahmed Elwassief; Ahmed Alashker; Abdallah Mahmoud Abdallah
Journal:  World J Hepatol       Date:  2015-06-28

3.  Prevalence of occult hepatitis B virus infection in kidney transplant recipients.

Authors:  Cibele Franz; Renata de Mello Perez; Mariano Gustavo Zalis; Ana Carolina Jonard Zalona; Pedro Túlio Monteiro de Castro e Abreu Rocha; Renato Torres Gonçalves; Letícia Cancella Nabuco; Cristiane Alves Villela-Nogueira
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

Review 4.  Molecular mechanisms underlying occult hepatitis B virus infection.

Authors:  Jasmine Samal; Manish Kandpal; Perumal Vivekanandan
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 5.  Prevalence of occult hepatitis B virus infection.

Authors:  Maria Luisa Gutiérrez-García; Conrado M Fernandez-Rodriguez; Jose Luis Lledo-Navarro; Ingrid Buhigas-Garcia
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

6.  Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients.

Authors:  Pankaj Jain; Sandeep Nijhawan
Journal:  World J Gastroenterol       Date:  2008-04-14       Impact factor: 5.742

7.  Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece.

Authors:  Paraskevi Mina; Sarah P Georgiadou; Christos Rizos; George N Dalekos; Eirini I Rigopoulou
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

8.  Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients.

Authors:  Mohammad Kazemi Arababadi; Behzad Nasiri Ahmadabadi; Hassan Yousefi Daredor; Derek Kennedy
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

9.  Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities.

Authors:  Mohammad Kazemi Arababadi; Gholamhossein Hassanshahi; Ali Akbar Pourfathollah; Ebrahim Rezazadeh Zarandi; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-09       Impact factor: 0.660

Review 10.  Occult hepatitis B infection and its possible impact on chronic hepatitis C virus infection.

Authors:  Peiman Habibollahi; Saeid Safari; Nasser E Daryani; Seyed M Alavian
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.